Polson R J, Rolles K, Calne R Y, Williams R, Marsden D
Liver Unit, King's College Hospital, Denmark Hill, London.
Q J Med. 1987 Aug;64(244):685-91.
Experience with liver transplantation for patients with Wilson's disease who have major neurological impairment is limited, and this report describes the results obtained in two such patients. The first was a 30-year-old man with a 14-month history of hepatic and neurological impairment. In spite of treatment with d-penicillamine, he developed increasing dysarthria, dysphagia, akinesia and rigidity of all four limbs, and required continuous nursing care. Following transplantation, liver function was almost normal from four weeks onwards, but recovery of neurological function was much slower and was not seen until two to three months after surgery. By four months he was sufficiently mobile to be discharged, and when he returned for assessment at eight months, no abnormal neurological signs were detectable. The second patient was a 27-year-old woman with worsening liver dysfunction for eight years; one year previously she had developed dysarthria, akinesia, a fine tremor and moderate rigidity of all limbs as well as marked psychological impairment. There was no improvement on treatment with d-penicillamine or trientine, but as liver function returned to normal two months after liver grafting, her neurological and psychological function began to improve so that by three months she could be discharged.
对于患有严重神经功能障碍的威尔逊病患者,肝移植经验有限,本报告描述了两名此类患者的治疗结果。第一名患者是一名30岁男性,有14个月的肝脏和神经功能障碍病史。尽管使用青霉胺治疗,他仍出现构音障碍、吞咽困难、运动不能及四肢僵硬加重,需要持续护理。移植后,四周起肝功能几乎恢复正常,但神经功能恢复慢得多,术后两到三个月才出现恢复。到四个月时,他活动能力足以出院,八个月复诊时未发现异常神经体征。第二名患者是一名27岁女性,肝功能恶化八年;一年前出现构音障碍、运动不能、轻微震颤及四肢中度僵硬,还有明显心理障碍。使用青霉胺或曲恩汀治疗均无改善,但肝移植术后两个月肝功能恢复正常,其神经和心理功能开始改善,三个月时可以出院。